From Prototype to Profit: Commercialization Insights

A landmark clinical trial suggests a different form of folate may be better for pregnancy, reducing a controversial byproduct without sacrificing key benefits.

With the addition of industry veteran Peter W. Wilson, Hamilton signals a reinforced focus on disciplined underwriting and strategic global growth.

The Austin-based deli chain partners with influencer Owen Han, betting on generous portions and premium ingredients to win over frustrated consumers.

The labor compliance software firm is the first in its niche to gain this elite federal security status, reshaping the market for government projects.

A pioneering, fully uncrewed mission charts deep-sea corals, aiding environmental recovery and showcasing the future of maritime technology.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

A new forecast sees robust refining margins into the next decade, driven by geopolitical turmoil, project delays, and soaring demand for diesel and jet fuel.

New Eagle's new OpenECU NX3 consolidates megawatt charging and vehicle control into one unit, promising to slash complexity and speed up EV development.

The firm that custodies $114 trillion in assets is launching a tokenization service, backed by the SEC and 50+ industry giants. Here's what it means.

A devastating infant liver disorder meets a potential breakthrough. Satellite Bio's novel cell therapy just received a critical FDA nod, paving the way for trials.

Kathryn Cullen joins NAPA Anesthesia as President of Clinical Services, bringing a track record of operational excellence to a challenging healthcare landscape.

A new partnership delivers a domestically-made BESS control system, tackling strict federal regulations and securing the US clean energy supply chain.

Cobb County partners with Vera Whole Health, signaling a major shift in public sector benefits toward proactive, value-based primary care for its workforce.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

The Canadian miner's new OTCQB listing aims to attract American capital, fueling exploration of its promising gold and copper assets in British Columbia.

Independence Realty Trust posts stable Q1 results, leaning on renovations and shrewd financing as it affirms its 2026 outlook despite market pressures.

Amid rising student anxiety and digital burnout, a new initiative is deploying certified therapy cats to campuses for a much-needed, screen-free dose of calm.

With three powerhouse appointments, ProgenyHealth signals a major push to tackle America's maternal health crisis and redefine high-risk infant care.

Italian biopharma giant Chiesi makes its largest acquisition ever, targeting KalVista's groundbreaking oral HAE drug to reshape patient care and its future.

The investment bank reports a 100% revenue surge, raises dividends, and outpaces rivals, signaling a potential renaissance for the entire M&A sector.